Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani 2630, Toyama, 930-0194, Japan.
Beilstein J Org Chem. 2007;3:30. doi: 10.1186/1860-5397-3-30. Epub 2007 Sep 28.
The 5,8-disubstituted indolizidines constitute the largest class of poison-frog alkaloids. Some alkaloids have been shown to act as noncompetitive blockers at nicotinic acetylcholine receptors but the proposed structures and the biological activities of most of the 5,8-disubstituted indolizidines have not been determined because of limited supplies of the natural products. We have therefore conducted experiments to confirm proposed structures and determine biological activities using synthetic compounds. Recently, we reported that one of this class of alkaloids, (-)-235B', acts as a noncompetitive antagonist for α4β2 nicotinic receptors, and its sensitivity is comparable to that of the classical competitive antagonist for this receptor, dihydro-β-erythroidine.
The enantioselective syntheses of (-)-209B, (-)-231C, (-)-233D, (-)-235B", (-)-221I, and what proved to be an epimer of natural 193E, starting from common chiral lactams have been achieved. When we performed electrophysiological recordings to examine the effects of the synthetic alkaloids on two major subtypes of nicotinic receptors (α4β2 and α7) expressed in Xenopus laevis oocytes, (-)-231C effectively blocked α4β2 receptor responses (IC(50 )value, 1.5 μM) with a 7.0-fold higher potency than for blockade of α7 receptor responses. In contrast, synthetic (-)-221I and (-)-epi-193E were more potent in blocking α7 receptor responses (IC(50 )value, 4.4 μM and 9.1 μM, respectively) than α4β2 receptor responses (5.3-fold and 2.0-fold, respectively).
We achieved the total synthesis of (-)-209B, (-)-231C, (-)-233D, (-)-235B", (-)-221I, and an epimer of 193E starting from common chiral lactams, and the absolute stereochemistry of natural (-)-233D was determined. Furthermore, the relative stereochemistry of (-)-231C and (-)-221I was also determined. The present asymmetric synthesis of the proposed structure for 193E revealed that the C-8 configuration of natural 193E should be revised. The selectivity for α4β2 and α7 nicotinic receptors differed markedly for the 5,8-disubstituted indolizidines tested, and thus it appears that the nature of the side chains in these indolizidines is crucial with regard to subtype-selectivity.
5,8-取代的吲哚里西啶是毒蛙生物碱中最大的一类。一些生物碱已被证明作为烟碱型乙酰胆碱受体的非竞争性阻滞剂,但由于天然产物供应有限,大多数 5,8-取代的吲哚里西啶的结构和生物活性尚未确定。因此,我们进行了实验,使用合成化合物来证实提出的结构并确定生物活性。最近,我们报道了该类生物碱之一(-)-235B',作为α4β2 烟碱受体的非竞争性拮抗剂,其敏感性与该受体的经典竞争性拮抗剂二氢-β-erythroidine 相当。
(-)-209B、(-)-231C、(-)-233D、(-)-235B"、(-)-221I 和被证明是天然 193E 的差向异构体,从常见的手性内酰胺开始,实现了对映选择性合成。当我们进行电生理记录以检查合成生物碱对在非洲爪蟾卵母细胞中表达的两种主要烟碱受体(α4β2 和 α7)的影响时,(-)-231C 有效地阻断了α4β2 受体反应(IC50 值为 1.5 μM),其效力比阻断α7 受体反应高 7 倍。相比之下,(-)-221I 和(-)-epi-193E 合成物在阻断α7 受体反应(IC50 值分别为 4.4 μM 和 9.1 μM)方面比α4β2 受体反应(分别为 5.3 倍和 2.0 倍)更有效。
我们从常见的手性内酰胺开始,实现了(-)-209B、(-)-231C、(-)-233D、(-)-235B"、(-)-221I 和天然(-)-233D 的外消旋体的全合成,并确定了天然(-)-233D 的绝对立体化学。此外,(-)-231C 和(-)-221I 的相对立体化学也得到了确定。对天然 193E 的提议结构进行的不对称合成表明,天然 193E 的 C-8 构型应予以修正。测试的 5,8-取代的吲哚里西啶对α4β2 和α7 烟碱受体的选择性有显著差异,因此,这些吲哚里西啶中侧链的性质对于亚型选择性至关重要。